GO:0032368 regulation of lipid transport: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032368 (regulation of lipid transport) describes any process that modulates the frequency, rate or extent of directed lipid movement into, out of, or within a cell, or between cells, via transporters or pores.
• Lipid transport regulation is central to energy homeostasis, membrane biogenesis, and signaling, and its dysregulation contributes to metabolic, cardiovascular, and neoplastic disease.
• Key molecular players include lipid transfer proteins (e.g., STARD4), ABC transporters (ABCB1, ABCG2), perilipin-family droplet proteins (LSD2), and sphingosine-1-phosphate handling enzymes.
• Secondary active transporters couple ion gradients to lipid translocation, and lipids themselves modulate transporter activity, creating bidirectional regulatory loops.
• Natural molecules and dietary factors (e.g., vitamin E, phytochemicals) can regulate cholesterol and lipid transport, offering nutraceutical intervention points.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of lipid transport regulators in physiologically relevant cell systems.
Description
GO:0032368, regulation of lipid transport, is a biological process ontology term defined as any process that modulates the frequency, rate or extent of the directed movement of lipids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are hydrophobic or amphipathic molecules that cannot freely diffuse through aqueous environments; their movement therefore requires dedicated transport machinery and tight regulation. This term captures the regulatory layer that controls when, where, and how much lipid is moved, rather than the transport event itself. Understanding GO:0032368 is essential because lipid distribution underpins membrane integrity, energy storage, signal transduction, and systemic metabolic balance. Dysregulation of lipid transport regulation is implicated in atherosclerosis, obesity, insulin resistance, cancer multidrug resistance, and neurodegenerative conditions. The process spans multiple scales: intracellular sterol transfer by STARD4, lipid-droplet motility controlled by perilipin homologs such as LSD2, intestinal absorption of lipophilic vitamins, sphingosine-1-phosphate metabolism and export, and ATP-binding cassette transporter regulation by membrane lipids. Because these events are genetically tractable, researchers increasingly use CRISPR-engineered cell models to assign causal roles to specific regulators within GO:0032368.
regulation of lipid transport At A Glance
| GO ID | GO:0032368 |
|---|---|
| GO term | regulation of lipid transport |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Modulates the frequency, rate or extent of directed lipid movement into, out of, or within a cell, or between cells, via transporters or pores |
| Biological context | Energy homeostasis, membrane biogenesis, lipid signaling, lipoprotein metabolism, intestinal absorption |
| Representative regulators | STARD4, ABCB1, ABCG2, LSD2 (perilipin homolog), sphingosine-1-phosphate enzymes |
| Disease relevance | Metabolic disorders, cardiovascular disease, cancer chemoresistance, neurological conditions |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, lipid flux assays, imaging, omics |
What Is GO:0032368?
In practical terms, GO:0032368 refers to the collection of regulatory mechanisms that set the pace and direction of lipid movement across and within cellular compartments. It does not describe the physical translocation reaction itself, but rather the processes that modulate that translocation, including changes in transporter abundance, activity, localization, or the availability of lipid substrates. The QuickGO definition emphasizes modulation of frequency, rate, or extent of directed lipid movement, whether the movement is into a cell (uptake), out of a cell (efflux), or between intracellular compartments, and whether it is mediated by a transporter, a pore, or a carrier protein. This regulatory scope includes transcriptional, post-transcriptional, and post-translational control of transport machinery, as well as lipid-dependent modulation of transporter function.
Why Is regulation of lipid transport Important in Cell Biology?
Regulation of lipid transport (GO:0032368) is important because lipids are indispensable for membrane architecture, energy storage, and signaling, yet their hydrophobic nature demands controlled movement. When this regulation fails, cells accumulate or mislocalize lipids, leading to metabolic dysfunction, lipotoxicity, and disease. Moreover, lipid transport regulators influence drug pharmacokinetics and resistance, as exemplified by ABCB1 and ABCG2, whose activity is modulated by membrane lipids. Understanding GO:0032368 therefore informs therapeutic strategies in cardiometabolic disease, oncology, and nutrition.
• Maintains cellular lipid homeostasis and membrane lipid composition.
• Controls intestinal absorption of dietary lipids and lipophilic vitamins such as vitamin E.
• Regulates cholesterol distribution and steroidogenesis via sterol transfer proteins like STARD4.
• Modulates lipid-droplet trafficking and storage dynamics through perilipin homologs such as LSD2.
• Governs sphingosine-1-phosphate metabolism and export, impacting immune and vascular biology.
• Influences multidrug transporter activity and cancer chemoresistance through lipid-protein interactions.
• Provides mechanistic links between ion gradients and lipid translocation via secondary active transport.
• Offers targets for natural molecules and nutraceuticals that modulate cholesterol transport.
• Underpins energy balance and systemic glucose-lipid crosstalk in health and disease.
• Enables CRISPR-based causal validation of candidate lipid transport regulators.
What Happens During regulation of lipid transport?
Sensing lipid status and transport demand
In simple terms: Cells first check how much lipid they have and how much they need to move.
Regulation of lipid transport begins with sensing mechanisms that detect lipid availability, membrane composition, and metabolic demand. Cells adjust transport rates in response to changes in cholesterol levels, fatty acid supply, and sphingolipid pools. For example, stable reduction of STARD4 alters cholesterol regulation and lipid homeostasis, indicating that sterol transfer proteins participate in feedback sensing. Lipid-sensing pathways also intersect with glucose and lipid metabolic networks, coordinating transport with energy status.
Modulating transporter and carrier abundance
In simple terms: The cell changes how many transporter proteins are available to move lipids.
A major regulatory layer involves controlling the expression, trafficking, and stability of lipid transporters and carriers. ABCB1 and ABCG2 multidrug transporters are regulated by their lipid environment, and their activity depends on membrane lipid composition. Sphingosine-1-phosphate transport is regulated through the expression and activity of specific transporters and metabolic enzymes. In the intestine, membrane transporters for vitamin E are regulated to match dietary intake.
Post-translational and lipid-dependent control of transport activity
In simple terms: Transporters can be switched on or off by modifications and by the lipids around them.
Beyond abundance, transport activity is tuned post-translationally and allosterically. Lipids themselves act as regulators of transporter function, as shown for ABCB1 and ABCG2. Secondary active transporters couple ion gradients to substrate movement, and their coupling efficiency can be influenced by the lipid bilayer. Such lipid-protein interplay creates bidirectional regulation where transport changes membrane composition, which in turn feeds back on transporter activity.
Intracellular lipid transfer and droplet dynamics
In simple terms: Inside the cell, lipids are shuttled between organelles and stored in droplets.
Intracellular lipid transport is regulated by lipid transfer proteins and droplet-associated factors. STARD4 reduction perturbs cholesterol regulation and lipid homeostasis, highlighting its role in intracellular sterol movement. Lipid-droplet transport is regulated by the perilipin homolog LSD2, which controls droplet motility. These mechanisms ensure lipids reach appropriate organelles and storage sites.
Systemic and dietary modulation of lipid transport
In simple terms: Diet and natural compounds can dial lipid transport up or down.
At the organismal level, dietary components and natural molecules regulate lipid transport. Vitamin E intestinal absorption depends on regulated membrane transport across enterocytes. Natural molecules have been shown to modulate cholesterol transport, providing nutraceutical avenues. These systemic inputs integrate with cellular regulatory networks to maintain lipid balance.
Key Genes Involved in GO:0032368 regulation of lipid transport
The following genes and proteins represent major regulators and effectors within GO:0032368, spanning sterol transfer, ABC transport, lipid-droplet dynamics, sphingolipid handling, and intestinal absorption.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STARD4 | Intracellular sterol transfer protein | Stable reduction alters cholesterol regulation and lipid homeostasis |
| ABCB1 | ATP-binding cassette multidrug transporter | Lipid-regulated transporter activity linked to chemoresistance |
| ABCG2 | ATP-binding cassette transporter | Lipid-dependent regulation of transport function |
| LSD2 | Perilipin homolog regulating lipid-droplet transport | Controls droplet motility and storage dynamics |
| SPHK1 | Sphingosine kinase producing S1P | Regulates sphingosine-1-phosphate metabolism and transport |
| SPNS2 | Sphingosine-1-phosphate transporter | Mediates S1P export and signaling |
| NPC1L1 | Intestinal cholesterol uptake transporter | Regulates dietary cholesterol absorption |
| ABCA1 | Cholesterol efflux transporter | Modulates cholesterol transport and HDL biogenesis |
| SCARB1 | HDL receptor mediating selective cholesterol uptake | Regulates cholesterol transport in liver and steroidogenic tissues |
| CETP | Cholesteryl ester transfer protein | Regulates lipoprotein lipid transfer |
| APOA1 | Major HDL apolipoprotein | Controls cholesterol transport and reverse cholesterol transport |
| APOB | Major LDL/VLDL apolipoprotein | Regulates lipoprotein lipid delivery |
| MTTP | Microsomal triglyceride transfer protein | Regulates lipoprotein assembly and lipid transport |
| FABP1 | Fatty acid binding protein | Regulates intracellular lipid trafficking |
| CD36 | Fatty acid translocase | Regulates fatty acid uptake and lipid transport |
| SLC27A1 | Fatty acid transport protein | Regulates long-chain fatty acid uptake |
| CYP27A1 | Sterol 27-hydroxylase | Regulates cholesterol catabolism and transport |
How Is regulation of lipid transport Regulated?
Regulation of lipid transport (GO:0032368) is itself regulated at multiple levels. Metabolic signaling pathways that coordinate glucose and lipid metabolism, such as insulin and nutrient-sensing cascades, adjust transport capacity according to energy status. Lipid-sensing transcription factors and post-translational modifications control the abundance and activity of transporters and transfer proteins. Membrane lipid composition acts as a local regulator of transporter function, as demonstrated for ABCB1 and ABCG2. In addition, ion gradients provide the driving force for secondary active transport, and their maintenance indirectly regulates lipid translocation. Dietary and natural molecule inputs further modulate cholesterol and vitamin E transport. Sphingosine-1-phosphate transport is regulated by the balance between synthesis, degradation, and export machinery.
regulation of lipid transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCB1 | Cancer multidrug resistance | Knockout and point-mutation cell lines to test lipid-dependent transport |
| ABCG2 | Cancer chemoresistance, gout | Knock-in of variant alleles to assess transport regulation |
| STARD4 | Cholesterol homeostasis disorders | Stable knockdown or knockout to measure sterol transfer |
| SPNS2 | Immune and vascular S1P signaling | Knockout models to track S1P export |
| NPC1L1 | Hypercholesterolemia | Overexpression and knockout to study cholesterol uptake |
Metabolic and cardiovascular disease
Dysregulation of lipid transport regulation contributes to dyslipidemia, atherosclerosis, and metabolic syndrome. Altered cholesterol transport and lipoprotein metabolism are central to cardiovascular risk. Natural molecules that modulate cholesterol transport are being explored for therapeutic benefit. Intestinal absorption of lipids and lipophilic vitamins is also a regulatory node relevant to nutrition and metabolic health.
Cancer and chemoresistance
ABCB1 and ABCG2 are multidrug transporters whose activity is regulated by lipids, linking GO:0032368 to cancer chemoresistance. Lipid transport changes can affect drug distribution and membrane drug availability. Sphingosine-1-phosphate transport and signaling also influence tumor microenvironment and cell survival.
Neurological and lysosomal storage disorders
Intracellular sterol and sphingolipid transport defects are associated with neurodegenerative and lysosomal storage conditions. STARD4-dependent cholesterol regulation affects cellular lipid homeostasis, and its perturbation may impact neuronal lipid balance. Sphingosine-1-phosphate metabolism is critical in the nervous system and immune cell trafficking.
From regulation of lipid transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for lipid transport regulation? | CRISPR knockout cell line |
| Does a specific amino acid change alter transporter activity? | CRISPR point-mutation knock-in |
| Does a disease-associated variant affect lipid flux? | CRISPR knock-in of the variant allele |
| Where does a lipid transport regulator localize? | Tagged knock-in with fluorescent or epitope tag |
| Does increased expression of a regulator enhance lipid transport? | CRISPR overexpression (safe-harbor knock-in) |
| Which genes modulate lipid transport in a genome-wide manner? | CRISPR library screening with lipid flux readout |
How to Study the regulation of lipid transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent lipid uptake/efflux assay | Rate of lipid transport | Testing regulators of cholesterol and fatty acid movement |
| Radiolabeled lipid flux | Directional lipid transport | Quantifying sterol transfer and lipoprotein uptake |
| Live-cell imaging | Lipid droplet and organelle dynamics | Studying droplet transport regulation by LSD2 |
| CRISPR knockout screen | Genes required for lipid transport | Genome-wide discovery of regulators |
| Proteomics | Protein abundance and interactions | Identifying transport complexes and modifications |
| Membrane transport assay | Transporter activity and lipid dependence | Analyzing ABCB1/ABCG2 regulation |
| Sphingolipid profiling | S1P and related species | Assessing S1P metabolism and export |
| Intestinal absorption assay | Vitamin E and lipid uptake | Studying enterocyte transport regulation |
Lipid flux and transport assays
Direct measurement of lipid transport uses fluorescent or radiolabeled lipid analogs, cholesterol efflux assays, and lipoprotein uptake assays. These methods quantify the rate and extent of lipid movement and are used to test regulators identified in GO:0032368.
Imaging of lipid droplets and organelles
Live-cell imaging with lipid droplet dyes and tagged proteins reveals spatial regulation of lipid transport. Studies of LSD2-dependent droplet transport exemplify how imaging links regulators to motility.
Omics and CRISPR screening
Transcriptomics, proteomics, and CRISPR library screens identify genes that regulate lipid transport. These approaches can nominate transporters, transfer proteins, and signaling components for functional validation.
Biochemical and biophysical assays
Membrane reconstitution, transport assays, and lipid-binding measurements define how lipids modulate transporter activity. Such work has clarified lipid regulation of ABCB1 and ABCG2 and ion-coupled transport mechanisms.
How CRISPR Can Be Used to Study GO:0032368 regulation of lipid transport
Knockout
CRISPR knockout of candidate genes such as STARD4, ABCB1, or SPNS2 allows researchers to test whether the gene is required for lipid transport regulation. Loss-of-function models reveal baseline contributions and compensatory pathways.
Point Mutation
Point-mutation knock-in can dissect specific residues or regulatory sites within transporters and transfer proteins. This is valuable for testing lipid-binding motifs or phosphorylation sites implicated in GO:0032368.
Knock-in
Knock-in of disease-associated variants or tagged alleles enables physiological expression of modified proteins. Tagged knock-in supports localization and interaction studies of lipid transport regulators.
Overexpression
CRISPR-mediated overexpression via safe-harbor insertion can test gain-of-function effects on lipid transport. This complements knockout by revealing sufficiency of a regulator to alter lipid flux.
How EDITGENE Supports regulation of lipid transport Research
Researchers studying regulation of lipid transport-related genes often need to determine whether a candidate gene is causally involved in lipid movement or merely correlated with it. CRISPR-based cell models provide the controlled genetic perturbations required to establish causality, from complete loss of function to precise point mutations and tagged alleles. EDITGENE supports this workflow with end-to-end CRISPR services tailored to GO:0032368 research.
Contact EDITGENE today to design your custom CRISPR model for regulation of lipid transport research.
Frequently Asked Questions About regulation of lipid transport
What is GO:0032368 regulation of lipid transport?
GO:0032368 is a biological process ontology term defined as any process that modulates the frequency, rate or extent of the directed movement of lipids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore.
What genes are involved in regulation of lipid transport?
Key genes include STARD4, ABCB1, ABCG2, LSD2, SPHK1, SPNS2, NPC1L1, ABCA1, SCARB1, CETP, APOA1, APOB, MTTP, FABP1, CD36, SLC27A1, and CYP27A1.
Why is regulation of lipid transport important?
It maintains membrane composition, energy balance, and lipid signaling; its dysregulation contributes to metabolic, cardiovascular, and neoplastic disease.
How do ABC transporters regulate lipid transport?
ABCB1 and ABCG2 are multidrug transporters whose activity is modulated by membrane lipids, linking lipid environment to transport function and chemoresistance.
What is the role of STARD4 in lipid transport?
STARD4 is an intracellular sterol transfer protein; stable reduction of STARD4 alters cholesterol regulation and lipid homeostasis.
How is sphingosine-1-phosphate transport regulated?
S1P transport is regulated by synthesis, degradation, and export machinery, including specific transporters and metabolic enzymes.
Can diet regulate lipid transport?
Yes, dietary factors and natural molecules can modulate cholesterol transport, and vitamin E absorption depends on regulated intestinal membrane transport.
What methods study regulation of lipid transport?
Common methods include fluorescent lipid flux assays, radiolabeled transport, live-cell imaging, CRISPR screens, proteomics, and sphingolipid profiling.
How are CRISPR models used in lipid transport research?
CRISPR knockout, point mutation, knock-in, and overexpression enable causal testing of candidate regulators in lipid transport pathways.
What diseases are linked to lipid transport dysregulation?
Metabolic and cardiovascular diseases, cancer chemoresistance, and neurological or lysosomal storage conditions are linked to altered lipid transport regulation.
Conclusion
GO:0032368, regulation of lipid transport, defines the regulatory control of directed lipid movement across and within cells. It integrates sterol transfer proteins, ABC transporters, lipid-droplet regulators, sphingolipid machinery, and dietary inputs into a coherent homeostatic network. Because dysregulation of this process underlies major human diseases, precise genetic models are essential. CRISPR-based knockout, point-mutation, knock-in, and overexpression approaches, combined with lipid flux assays and omics, provide the tools to dissect causality within GO:0032368. EDITGENE offers integrated services to accelerate this research.
References
- 1. Chen L et al.. 2019. Regulation of glucose and lipid metabolism in health and disease.. Sci China Life Sci 62(11):1420-1458 PMID: 31686320
- 2. Drew D et al.. 2024. Ion and lipid orchestration of secondary active transport.. Nature 626(8001):963-974 PMID: 38418916
- 3. Tan M et al.. 2021. Recent developments in the regulation of cholesterol transport by natural molecules.. Phytother Res 35(10):5623-5633 PMID: 34327759
- 4. Hegedüs C et al.. 2015. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters.. Adv Cancer Res 125:97-137 PMID: 25640268
- 5. Iaea DB et al.. 2020. Stable reduction of STARD4 alters cholesterol regulation and lipid homeostasis.. Biochim Biophys Acta Mol Cell Biol Lipids 1865(4):158609 PMID: 31917335
- 6. Welte MA et al.. 2005. Regulation of lipid-droplet transport by the perilipin homolog LSD2.. Curr Biol 15(14):1266-75 PMID: 16051169
- 7. Reboul E. 2019. Vitamin E intestinal absorption: Regulation of membrane transport across the enterocyte.. IUBMB Life 71(4):416-423 PMID: 30308094
- 8. Liu X et al.. 2012. Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells.. Mol Cell Biochem 363(1-2):21-33 PMID: 22113622
